Odense University Hospital (OUH) is the largest[citation needed] and most specialized hospital[citation needed][clarification needed] in Southern Denmark.OUH is both Odense's and Funen's largest single workplace (Odense Municipality employs significantly more, but they are spread over many addresses). It has a budget of 835 million Euro and has 11.000 employees. OUH acts as a local and acute hospital in the northern part of Funen, but takes patients from all over Denmark, as it has highly specialized units within hand replantation surgery and special neuro-radiological intervention. In addition to reading Driver, OUH has an extensive research activity, and annually trains 2.500 people as part of either basic or continuing education.The hospital tower block, constructed in 1960, is 57 metres (187 ft) high, has 15 floors and is Odense's tallest building.[citation needed] Hospital Pharmacy Fyn is located at the university hospital. From the university hospital area there is a walkway to the Odense Sygehus Station operated by Svendborgbanen.OUH has for several years had the organizational Middelfart Hospital under it, but since 2008 also the former hospitals under the organizational name Funen Hospital, which are the County of Funen's smaller hospitals, became part of OUH. This concerns Svendborg Hospital, Dagklinik Faaborg, Hospital Unit Nyborg, Hospital Unit Ringe and Hospital Unit Aero..
PFAS are a group of persistent organic pollutants, that bioaccumulate and are associated with negative health effects. Reviews have suggested that the most critical effects of PFAS are on the immune system, but little is known of effects on development of autoimmunity. Our objective was to map and summarize available evidence concerning exposure to any PFAS and development/presence of autoimmunity, in humans and animals. We assessed studies reporting potential associations between PFAS exposure and autoimmune disease and/or autoantibodies. We searched MEDLINE, Embase, CENTRAL, Scopus, and Web of Science (02.15.2024) and conducted complimentary searches. Results were presented descriptively and we categorized autoimmune diseases and autoantibodies into relevant outcome groups. 51 studies were included, distributed in the following groups: Autoimmune thyroid disease, inflammatory bowel disease, rheumatoid arthritis, systemic lupus erythematosus, type 1 diabetes, celiac disease, other diseases and autoantibodies. Cross-sectional studies were most common, limiting opportunities for causal inference. 33 studies showed associations between higher PFAS and increased risk of autoimmunity, while nine studies found lower PFAS associated with increased autoimmunity risk. The results suggest that PFAS have negative health impacts with strongest evidence for celiac and inflammatory bowel disease, weaker evidence for rheumatoid arthritis, systemic lupus erythematosus and type 1 diabetes mellitus. No clear indications of association with autoimmune thyroid disease. The majority of the studies showed an association between PFAS and autoimmunity. There is a need for more longitudinal and dose–response studies, to improve our understanding of individual autoimmunity outcomes in the future. Protocol registration: OSF.io ( https://doi.org/10.17605/OSF.IO/3FEVQ ).
To assess temporal changes in the timing of pulmonary valve replacement (PVR) among patients with tetralogy of Fallot and to determine whether temporal shifts toward earlier PVR were accompanied by differences in ventricular volumes, ventricular function and exercise capacity after PVR. The timing of PVR was evaluated in a national, retrospective cohort using the Aalen-Johansen method to estimate cumulative incidence while accounting for death as competing risk. Trends in ventricular volumes, ventricular function and exercise capacity were assessed in patients with prior PVR, who underwent cardiac imaging and exercise testing in a cross-sectional study using robust linear regression. Among 463 potential candidates for PVR in the retrospective cohort, estimated time from repair to PVR was 34 years, 22 years and 16 years in patients born in 1940–1976, 1977–1999, and 2000–2021, respectively (p < 0.001). In total, 153 patients with prior PVR born between 1942 and 2009 were examined in the cross-sectional study. Estimated right ventricular end-systolic volume index was lower by 5.43 mL/m2 per decade (p = 0.02), estimated right ventricular ejection fraction increased by 2.08 Overview of temporal changes in the timing of pulmonary valve replacement and impact on outcomes. The median time from repair to pulmonary valve replacement for each birth era was based on a nationwide cohort of patients with tetralogy of Fallot and estimated using the cumulative incidence function. The temporal trends in ventricular volumes, ventricular function and exercise capacity were estimated based on the results from patients who underwent cardiac magnetic resonance imaging, transthoracic echocardiography and cardiopulmonary exercise testing as part of a national multicentre cross-sectional study and estimated using robust regression methods
Abstract Objective This study seeks to assess the impact of quantum iterative reconstruction (QIR) on objective measures of contrast-to-noise ratio (CNR), lumen diameter, and stent strut thickness using photon-counting detector computed tomography (PCD-CT) in ultra-high resolution mode (UHR) in a coronary phantom. Materials and methods A three-dimensional printed phantom (four parallel vessels; 3 vessels with varying 3.5-mm stent types) was applied. Demineralized water, mixed with iodinated contrast, was circulated through the phantom by a dynamic pump. Images were acquired on a commercially available PCD-CT system using retrospective helical acquisition in UHR mode at both 120 and 140 kVp. Images were reconstructed at four QIR-levels (1‒4) using three sharp vascular kernels (Bv56u, Bv68u, and Bv76u). Quantitative evaluations of lumen diameter (mm) and stent strut thickness (mm) were assessed by attenuation profiles using an in-house MATLAB script. Results Increasing QIR level from 1 to 4 improved CNR from 1.5 (95% confidence interval [CI] 1.31‒1.70) (QIR-level 1) to 3.33 (95% CI: 2.89‒3.77) (QIR-level 4), p < 0.001. There was no change (QIR-level 1 to 4) in lumen diameter, range 2.95 mm (95% CI: 2.89‒3.02) to 2.97 mm (95% CI: 2.91‒3.03) (p = 0.890) or strut thickness, range 0.62 mm (95% CI: 0.59‒0.65) to 0.61 mm (95% CI: 0.58‒0.65 ((p = 0.870), regardless of contrast concentration or reconstruction kernel. Conclusion Increasing QIR-level in UHR mode PCD-CT in a stented coronary phantom improved CNR without affecting objective measures of lumen diameter or stent strut thickness under controlled phantom conditions. Relevance statement There has been debate regarding the negative impact of iterative reconstruction on spatial resolution, potentially increasing blooming artifacts caused by coronary stents, which is of special concern when imaging small stent lumens. Currently, no studies have assessed the effect of QIR on the objective assessment of coronary stents. Key Points Some earlier implementations of iterative reconstruction negatively impacted spatial resolution, raising concerns for small-vessel and stent imaging. No prior studies examined the effect of QIR on coronary stent assessment. The effect of QIR was evaluated at four levels (1‒4) in a stented coronary phantom. Increasing QIR to the highest level significantly improved luminal CNR. Objective measures of stent dimensions remained unchanged across all QIR levels. Graphical Abstract
This update and revision of the international guideline for urticaria was developed in accordance with the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. It is an initiative of the Global Allergy and Asthma Excellence Network (GA(2)LEN) and its Urticaria and Angioedema Centers of Reference and Excellence (UCAREs and ACAREs), with the participation of 210 delegates from 107 national and international societies, from 59 countries. The consensus conference was held on December 6th, 2024. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS). Urticaria is a frequent, mast cell-driven disease, defined by a rapid appearance of wheals, angioedema, or both. The lifetime prevalence of acute urticaria is estimated to be approximately 20%. Chronic urticaria, categorized as either chronic spontaneous urticaria or chronic inducible urticaria, is disabling, impairs quality of life, and affects performance at work and school, however, novel therapies are available. This updated version of the international guideline for urticaria covers the definition and classification of urticaria and outlines expert-guided and evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria.
A network meta-analysis was performed to evaluate the risk of congenital malformations and other prenatal outcomes in fetuses after exposure to antipsychotic medications and mood stabilizers during pregnancy. We searched the PubMed, EMBASE, and Cochrane CENTRAL databases up to 15 December 2023, to identify experimental and observational studies comparing antipsychotic and mood stabilizer treatments with control treatments (no exposure). The primary outcome of the study was the incidence of congenital malformations and the secondary outcomes were preterm birth and spontaneous abortion. Additionally, two authors independently assessed the risk of bias in each domain of the included studies using the ROBINS-I tool and evaluated the quality of evidence using the CINeMA rating tool. The literature search identified 18,334 potential records, and 22 studies involving 3,042,997 pregnant women were ultimately included. Compared with the unexposed group, quetiapine [odds ratio (OR), 1.19; 95
